INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Fatal crash closes I-465 ramp on west side
A fatal crash on I-465 near the intersection with I-70 closed a highway off-ramp on the west side Friday night.
Person struck, killed by train in Lawrence
A person was struck and killed by a train in Lawrence Friday.
'Pence Must Go' signs pop up around Indy
New signs of dissatisfaction with Gov. Mike Pence's job performance have begun popping up around Indianapolis.
IMPD meets with community in wake of shooting
Just days after a deadly police-involved shooting on the northeast side, IMPD officers and members of the community came together to discuss…
Vectren customers shocked by high gas bills
If you're a Vectren customer, you might want to double check your bills, Call 6 Investigator Kara Kenney reported.